You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 53 No. 6, June 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  BOOK REVIEWS
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pathogenesis and Therapy of Amyotrophic Lateral Sclerosis (Advances in Neurology—Volume 68)

edited by Georges T. Serratrice and Theodore L. Munsat, 312 pp, $115, Philadelphia, Pa, Lippincott-Raven Publishers, 1995.

David Goldblatt, MD, Reviewer
Rochester, NY

Arch Neurol. 1996;53(6):482.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The contents of this book come from a meeting about amyotrophic lateral sclerosis (ALS) conducted in October 1994, in Marseille, France, in which the "primary goal," according to one of the editors, was "to identify current controversies and propose solutions." As is often true in volumes that compile work from centers in several countries (in this case, France, the United States, Tunisia, Sweden, Canada, Hungary, England, Australia, Switzerland, and Italy), the controversies, for the most part, are only implicit in the articles themselves. Their solution is, perforce, left to another time and place. This is true despite the formal organization of the meeting (primary presenter followed by two designated discussants). The discussants usually present their own data, and the reader is left to make the connections. As an elementary example of what happens as a result, the Babinski sign in ALS is "rarely positive" (Munsat, p 212), "usually absent" (Marseille . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.